Genome-wide association analysis of opioid use disorder: A novel approach using clinical data
Authors:
- 15 September 2020
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 217, 108276
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute
- U.S. National Library of Medicine
This publication has 34 references indexed in Scilit:
- Measuring problem prescription opioid use among patients receiving long-term opioid analgesic treatment: development and evaluation of an algorithm for use in EHR and claims dataJournal of Drug Assessment, 2020
- Genome-wide Association Study Identifies a Regulatory Variant of RGMA Associated With Opioid Dependence in European AmericansBiological Psychiatry, 2018
- The Burden of Opioid-Related Mortality in the United StatesJAMA Network Open, 2018
- The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013Medical Care, 2016
- The Biobank Portal for Partners Personalized Medicine: A Query Tool for Working with Consented Biobank Samples, Genotypes, and Phenotypes Using i2b2Journal of Personalized Medicine, 2016
- LD Score regression distinguishes confounding from polygenicity in genome-wide association studiesNature Genetics, 2015
- Genome-Wide Association Study of Opioid Dependence: Multiple Associations Mapped to Calcium and Potassium PathwaysBiological Psychiatry, 2014
- A linear complexity phasing method for thousands of genomesNature Methods, 2011
- Addiction, Adolescence, and Innate Immune Gene InductionFrontiers in Psychiatry, 2011
- Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Drug Abuse and Dependence in the United StatesArchives of General Psychiatry, 2007